Re-Inventing Tumor Targeting
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for increased local drug concentrations and improved tumor penetration to achieve improved clinical treatment efficacy. The lead candidate THE001 is a thermosensitive formulation of doxorubicin being developed in soft tissue sarcoma.